30 results
8-K
EX-99.1
TLPH
Talphera Inc.
5 Aug 19
AcelRx Pharmaceuticals Reports Second Quarter 2019 Financial Results
4:10pm
appreciation of DSUVIA’s unique pharmacokinetic profile and route of administration is evident in the diversity of REMS-certified facilities
S-8
EX-99.1
4q3cdgl 766cox5xufnn
16 Jun 20
Registration of securities for employees
4:52pm
8-K
EX-10.1
x8jzqo
17 Jun 21
Departure of Directors or Certain Officers
5:11pm
8-K
EX-10.1
lxwta ggzz
10 Oct 23
Departure of Directors or Certain Officers
4:17pm
DEF 14A
oeyyygpj vp1q5uzr2
21 Jun 12
Definitive proxy
12:00am